COUGH is the #13 most commonly reported adverse reaction for ACETYLCYSTEINE, manufactured by Cumberland Pharmaceuticals Inc.. There are 292 FDA adverse event reports linking ACETYLCYSTEINE to COUGH. This represents approximately 1.6% of all 18,714 adverse event reports for this drug.
Patients taking ACETYLCYSTEINE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH292 of 18,714 reports
COUGH is a less commonly reported adverse event for ACETYLCYSTEINE, but still significant enough to appear in the safety profile.
Other Side Effects of ACETYLCYSTEINE
In addition to cough, the following adverse reactions have been reported for ACETYLCYSTEINE:
COUGH has been reported as an adverse event in 292 FDA reports for ACETYLCYSTEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with ACETYLCYSTEINE?
COUGH accounts for approximately 1.6% of all adverse event reports for ACETYLCYSTEINE, making it a notable side effect.
What should I do if I experience COUGH while taking ACETYLCYSTEINE?
If you experience cough while taking ACETYLCYSTEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.